piribedil has been researched along with Atherosclerotic Parkinsonism in 7 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind, cross-over trial of the effectiveness of piribedil, procyclidine and placebo in the control of parkinsonism induced by fluphenazine decanoate was conducted in sixteen cases of chronic schizophrenia." | 5.04 | A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism. ( Bradley, R; Lamb, P; Mindham, RH, 1977) |
| "Electromyographic (EMG) activity of abnormal involuntary movements and their modifications after Piribedil, a dopaminergic agonist, were analysed in patients presenting with tremor or tardive dyskinesia induced by treatment with neuroleptics." | 3.67 | EMG patterns in abnormal involuntary movements induced by neuroleptics. ( Bathien, N; Koutlidis, RM; Rondot, P, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bathien, N | 1 |
| Koutlidis, RM | 1 |
| Rondot, P | 1 |
| Smith, L | 1 |
| De Salvia, M | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| Mindham, RH | 2 |
| Corsini, GU | 1 |
| Del Zompo, M | 1 |
| Spissu, A | 1 |
| Mangoni, A | 1 |
| Gessa, GL | 1 |
| Lamb, P | 1 |
| Bradley, R | 1 |
| Poirier, LJ | 1 |
| Arbuthnott, GW | 1 |
| Murray, LG | 1 |
3 trials available for piribedil and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control.
Topics: Amantadine; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as T | 1976 |
Parkinsonism by haloperidol and piribedil.
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Haloperidol; Humans; Male; Parkinson Disease, S | 1978 |
A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism.
Topics: Chronic Disease; Clinical Trials as Topic; Fluphenazine; Humans; Parkinson Disease; Parkinson Diseas | 1977 |
4 other studies available for piribedil and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
EMG patterns in abnormal involuntary movements induced by neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Electromyography; Female; Humans; Male; | 1984 |
An appraisal of the antiparkinsonian activity of piribedil in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Antiemetics; Antiparkin | 1996 |
Dopaminergic agonists in animal models of parkinsonism.
Topics: Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Cats; Disease Models, Animal; Haplorhini; L | 1975 |
Dopamine receptor agonists in psychiatric disease.
Topics: Bipolar Disorder; Dopamine; Humans; Parkinson Disease, Secondary; Piperazines; Piribedil; Receptors, | 1975 |